Praxis Precision Medicines Inc [PRAX] stock prices are up 3.96% to $41.70 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PRAX shares have gain 4.12% over the last week, with a monthly amount drifted -6.86%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Praxis Precision Medicines Inc [NASDAQ: PRAX] stock has seen the most recent analyst activity on June 18, 2024, when Guggenheim initiated its Buy rating and assigned the stock a price target of $155. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 01, 2024, and set its price target to $117. On September 19, 2023, Truist initiated with a Buy rating and assigned a price target of $10 on the stock. Wedbush downgraded its rating to a Neutral but stick to its price target of $4 on June 06, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $48 as its price target on December 16, 2021. BofA Securities started tracking with a Buy rating for this stock on August 26, 2021, and assigned it a price target of $28. In a note dated April 26, 2021, William Blair initiated an Outperform rating.
The stock price of Praxis Precision Medicines Inc [PRAX] has been fluctuating between $12.75 and $67.21 over the past year. Currently, Wall Street analysts expect the stock to reach $141 within the next 12 months. Praxis Precision Medicines Inc [NASDAQ: PRAX] shares were valued at $41.70 at the most recent close of the market. An investor can expect a potential return of 238.13% based on the average PRAX price forecast.
Analyzing the PRAX fundamentals
The Praxis Precision Medicines Inc [NASDAQ:PRAX] reported sales of 2.19M for trailing twelve months, representing a drop of -36.90%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -59.3%, Pretax Profit Margin comes in at -57.12%, and Net Profit Margin reading is -57.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.02 and Total Capital is -0.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.03 points at the first support level, and at 38.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.02, and for the 2nd resistance point, it is at 44.34.
Ratios To Look Out For
It’s worth pointing out that Praxis Precision Medicines Inc [NASDAQ:PRAX]’s Current Ratio is 11.27. In addition, the Quick Ratio stands at 11.27 and the Cash Ratio stands at 8.09. Considering the valuation of this stock, the price to sales ratio is 325.79, the price to book ratio is 2.41.
Transactions by insiders
Recent insider trading involved DeSimone Jill, Director, that happened on Oct 05 ’23 when 14500.0 shares were purchased. Chief Executive Officer, Souza Marcio completed a deal on Jun 27 ’23 to buy 10000.0 shares.
